MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD
2018 · Blood · 202 citations
https://doi.org/10.1182/blood-2018-01-822957
A
Anne S. Renteria
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
68
Papers
2.0K
Citations
12
h-index
13
i10-index
Anne S. Renteria is an academic researcher from Winthrop-University Hospital. The author has contributed to research in topics: Hematopoietic Stem Cell Transplantation & Acute Myeloid Leukemia Research & Acute Lymphoblastic Leukemia research. The author has an h-index of 12, co-authored 58 publications.
ORCID: 0000-0001-7606-3321Papers by this author
worksA phase 2a randomized clinical trial of intravenous vedolizumab for the treatment of steroid-refractory intestinal acute graft-versus-host disease
2021 · Bone Marrow Transplantation · 17 citations
https://doi.org/10.1038/s41409-021-01356-0
AML with BCR-ABL1 Fusion treated with Imatinib, a Hypomethylating Agent and Venetoclax
2022 · Leukemia Research Reports · 3 citations
https://doi.org/10.1016/j.lrr.2022.100333
TCL-1031: Allogeneic Hematopoietic Cell Transplant in T-Cell Lymphoma in the Era of Post-Transplant Cyclophosphamide-Based Graft-vs-Host Disease Prophylaxis Regimens: A Single-Center Retrospective Analysis
2025 · Clinical Lymphoma Myeloma & Leukemia · 1 citations
https://doi.org/10.1016/s2152-2650(25)02523-6
ABCL-942: Pola-R-Mini-CHP for Untreated Diffuse Large B-Cell Lymphoma in Patients Who Are Elderly With Comorbid Conditions
2025 · Clinical Lymphoma Myeloma & Leukemia · 0 citations
https://doi.org/10.1016/s2152-2650(25)02325-0
Ancestry-associated social and genomic hallmarks linked with inferior outcome in elderly acute myeloid leukemia
2025 · BMC Cancer · 0 citations
https://doi.org/10.1186/s12885-025-14777-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat